| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/27/2002 | CN1342064A Soy depigmenting and skin care compositions |
| 03/27/2002 | CN1341599A Novel benzodiazine compound, its preparation method and medicine composition containing them |
| 03/27/2002 | CN1341593A Proteinase inhibitor |
| 03/27/2002 | CN1341592A Proteinase inhibitor |
| 03/27/2002 | CN1341591A Solution of tetrahydrate N-[ortho-(para-trimethyl acetoxyl benzenesulfonamide) benzoyl] glycine monosodium salt and its medicine |
| 03/27/2002 | CN1341590A Proteinase inhibitor |
| 03/27/2002 | CN1341588A Intermediate product for preparing substituted 2,4-thiazolidine diketone derivative |
| 03/27/2002 | CN1341445A Yanhou Longhusan powder for curing sore-throat and laryngopharyngitis |
| 03/27/2002 | CN1341443A Medicated liquor for curing burn and skin injury |
| 03/27/2002 | CN1341434A Medicine and health-care product formed from ganglioside and ginkgo leaf extract and their application |
| 03/27/2002 | CN1341420A Medicine formed from ganglioside and erigeron breviscapus extract and health-care product and their application |
| 03/27/2002 | CN1341419A Skin-care composition |
| 03/27/2002 | CN1341418A Synergistic type anti-cancer medicine |
| 03/27/2002 | CN1341417A Injection medicine composite presciption containing cefotaxime and tazolepatan |
| 03/27/2002 | CN1341416A Production method of aquatic product feed crystal amino acid slow-releasing preparation |
| 03/27/2002 | CN1341361A Preparation method of povidone-iodine |
| 03/27/2002 | CN1081672C Fungicdal methods and compositions for killing yeast and sporular microorganisms |
| 03/27/2002 | CN1081643C Cationic biopolymers and their preparation and use |
| 03/27/2002 | CN1081642C Method of producing starch decomposition products |
| 03/27/2002 | CN1081640C Diclavulanate salt of diamino ether and its preparing method |
| 03/27/2002 | CN1081639C Vinylpyrrolidinon cephalosporin derivatives |
| 03/27/2002 | CN1081638C Thienopyrimidines |
| 03/27/2002 | CN1081637C Radiosensitizing diamines and their pharmaceutical preparations |
| 03/27/2002 | CN1081635C Substituted pyrrolidine-3-Yl-alkyl-piperidines |
| 03/27/2002 | CN1081633C 1,2,4-benzothiadiazine derivatives, their preparation and use |
| 03/27/2002 | CN1081632C Form III crystalline (R-(R*,R*)-2-(4-fluorophenyl)-beta-delta-dihydroxy-5-(1-methyl-ethyl)-3-phenyl-4-((phenylamino)carbonyl)-1H-pyrrole-1-heptanoic acid hemi calcium salt (atorvastatin) |
| 03/27/2002 | CN1081631C N-methyl-N[(1S)-1-phenyl-2-(2S)-3-hydroxypyrrolidin-1-yl)ethyl]-2,2-diphenylacetamide |
| 03/27/2002 | CN1081625C 1-aryl-2-acylamino-ethane compounds and their use as meurokinin especially neurokinin 1 antagonists |
| 03/27/2002 | CN1081624C Benzamide analogs, useful as PARP (ADP-ribosyltransferase, ADRPT) DNA repair enzyme inhibitors |
| 03/27/2002 | CN1081461C Long-acting oxytracycline composition |
| 03/27/2002 | CN1081460C Use of medicine for reducing tissue damage associated with non-cardiac ischemia by aldose reductase inhibitor |
| 03/27/2002 | CN1081459C Transdermal delivery device |
| 03/27/2002 | CA2345606A1 Grain fractionation |
| 03/26/2002 | US6362392 Nude mouse model for the growth and treatment of human neurally-derived tumors |
| 03/26/2002 | US6362371 β2- adrenergic receptor agonists |
| 03/26/2002 | US6362360 Sensitizers for insulin resistance and associated conditions dyslipidemia and hyperglycemia |
| 03/26/2002 | US6362342 Biosynthesis; drug libraries |
| 03/26/2002 | US6362336 Administering a quinazoline derivative to a warm-blooded animal for producing an antiangiogenic and/or vascular permeability reducing effect |
| 03/26/2002 | US6362322 Conversion of a watson-crick DNA to a hoogsteen-paired duplex |
| 03/26/2002 | US6362319 Glial cell line-derived neurotrophic factor |
| 03/26/2002 | US6362237 Compounds with progesterone-antagonistic and antiestrogenic action to be used together for female contraception |
| 03/26/2002 | US6362236 Statin compound |
| 03/26/2002 | US6362234 Water-soluble prodrugs of propofol for treatment of migrane |
| 03/26/2002 | US6362233 Skin disorders |
| 03/26/2002 | US6362232 Skin disorers; insecticides |
| 03/26/2002 | US6362231 Calcium receptor active compounds |
| 03/26/2002 | US6362230 Alzheimer's disease |
| 03/26/2002 | US6362229 Inhibitors of multidrug transporters |
| 03/26/2002 | US6362228 Phenethyl-thiourea compounds and use |
| 03/26/2002 | US6362227 Methods for the treatment of tinnitus and other disorders using R(−)ketoptofen |
| 03/26/2002 | US6362226 Modulation of in vivo glutamine and glycine levels in the treatment of autism |
| 03/26/2002 | US6362225 Influenza, rhinovirus therapy usin lysine monohydrochloride |
| 03/26/2002 | US6362223 Cardiovascular disorders |
| 03/26/2002 | US6362222 Topical applying |
| 03/26/2002 | US6362221 Anticholesterol agents; antilipemic agents |
| 03/26/2002 | US6362220 Administering a sulfamic acid compound |
| 03/26/2002 | US6362219 Process for the preparation of a formulation of dihydroartemisinin for the control of wide spectrum of malaria |
| 03/26/2002 | US6362217 Antitumor agents |
| 03/26/2002 | US6362214 Thermodynamically stable form of (R)-3-[[(4-fluorophenyl) sulphonyl]amino]-1,2,3,4-tetrahydro-9H-carbazole-9-propanoic acid (ramatroban) |
| 03/26/2002 | US6362211 Polycyclic indanylimidazoles with alpha2 adrenergic activity |
| 03/26/2002 | US6362210 Carboxylic acid amides, pharmaceutical compositions containing these compounds and their use |
| 03/26/2002 | US6362209 Heterocyclic aromatic oxazole compounds and use thereof |
| 03/26/2002 | US6362207 Methods of treating viral infections with benzimidazoles |
| 03/26/2002 | US6362204 Controlling immunology; antiinflammatory agents |
| 03/26/2002 | US6362202 Methods and compositions using (−) norcisapride in combination with proton pump inhibitors or H2 receptor antagonists |
| 03/26/2002 | US6362200 Antitumor dibenzofluorene derivatives |
| 03/26/2002 | US6362199 Central nervous system disorders; psychological disorders |
| 03/26/2002 | US6362198 Anticholesterol, antilipemic agent |
| 03/26/2002 | US6362197 Using a quaternary ammonium compound |
| 03/26/2002 | US6362196 Method to treat pain utilizing benzimidazole NMDA/NR2B antagonists |
| 03/26/2002 | US6362195 Inhibitor of nitric oxide synthase; central nervous system disorders |
| 03/26/2002 | US6362194 Method and simultaneously enhancing analgesic potency and attenuating dependence liability caused by morphine and other bimodally-acting opioid agonists |
| 03/26/2002 | US6362193 Antiinflammatory agents |
| 03/26/2002 | US6362191 Aminometyl oxooxazolidinyl benzene derivatives |
| 03/26/2002 | US6362190 Administering compounds such as 3-(2-phenylethylamino)-6-methyl-1-(2-amino-6-methyl-5-methylene -carboxamidomethylpyridi nyl)-2-pyrazinone, n'-((1-(aminoiminomethyl)4-piperidinyl) methyl)-n-(3,3-diphenylpropionyl)-l-proline amide |
| 03/26/2002 | US6362185 Polyhydroxyalkylpyrazine derivatives, their preparation and the medicaments comprising them |
| 03/26/2002 | US6362184 Killing tumor cells |
| 03/26/2002 | US6362182 Hypotensive agents; anticholesterol agents; benign prostatic hypertropic |
| 03/26/2002 | US6362181 Bactericides; enzyme inhibitors; antitumor agents |
| 03/26/2002 | US6362180 Antagonist to corticotropin releasing factor |
| 03/26/2002 | US6362179 Psychological disorders; nervous system disorders |
| 03/26/2002 | US6362178 2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors |
| 03/26/2002 | US6362177 Cyclic amine derivatives and their use as drugs |
| 03/26/2002 | US6362176 Compositions, methods and kits for treating rheumatoid arthritis |
| 03/26/2002 | US6362173 Methods for treating psychosis associated with cocaine addiction with glucocorticoid receptor antagonists |
| 03/26/2002 | US6362172 Water soluble prodrugs of azole compounds |
| 03/26/2002 | US6362169 Antibacterial compositions with synergistic effect, drugs and remedies for digestive diseases containing the same, process for the production thereof and preparations associated therewith |
| 03/26/2002 | US6362168 Antiparasitic agents |
| 03/26/2002 | US6362167 Method of blocking free radical processes which result in mediated pathology without deleterious pro-oxidant side reactions |
| 03/26/2002 | US6362161 Copolymer-1 improvements on compositions of copolymers |
| 03/26/2002 | US6362160 Immunophilin-binding agents prevent glutamate neurotoxicity associated with vascular stroke and neurodegenerative diseases |
| 03/26/2002 | US6361997 Genetically modified CD34-negative adherently growing stem cells and their use in gene therapy |
| 03/26/2002 | US6361957 Assay for D-serine transport antagonist and use for treating psychosis |
| 03/26/2002 | US6361806 Composition for and method of topical administration to effect changes in subcutaneous adipose tissue |
| 03/26/2002 | US6361800 Vitamin and mineral supplements |
| 03/26/2002 | US6361795 Method for lowering blood glucose |
| 03/26/2002 | US6361794 Granulation of ibuprofen, hydrocodone bitartrate and silica |
| 03/26/2002 | US6361792 Fluorocarbon emulsion and nonsteroid antiinflammatory agent, antipyretic, nonnarcotic analgesic |
| 03/26/2002 | US6361785 Fungicides using camphor, menthol, eucalyptus oil and thymol |
| 03/26/2002 | US6361768 Hydrophilic ampholytic polymer |